ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

FTRE vs LLY // RETURN ON INVESTED CAPITAL (ROIC)

Fortrea Holdings Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: FTRE 1 — LLY 13
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: LLY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FTRE VS. LLY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC FTRE LLY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 41.00% 83.64% -42.64 LLY /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% 32.36% -67.36 LLY /roic <GO>
EV/EBITDA & P/E Valuation — 36.4x — TIE /valuation <GO>
Free Cash Flow Yield -0.41% 2.30% -2.71 LLY /fcf-yield <GO>
Operating Margin -32.00% 40.21% -72.21 LLY /operating-margins <GO>
Net Profit Margin -36.30% 31.90% -68.20 LLY /net-margins <GO>
Revenue Growth (YoY) 1.00% 45.51% -44.51 LLY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.49% -0.49 LLY /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.45 9.29 -8.84 LLY /balance-sheet <GO>
Piotroski F-Score Quality 3/9 9/9 -6.00 LLY /piotroski-score <GO>
Options Implied Move & Put/Call Skew 6.90% 6.77% +0.13 LLY /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.4 77.9 -31.49 LLY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.99 0.51 +0.48 FTRE /macro-sensitivity <GO>
Forward P/E Multiple 29.0x 26.3x +2.75 LLY /forward-pe <GO>
Enterprise Scale & Market Cap $2.20B $1.33T -$1.33T LLY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR FTRE REV LLY REV FTRE GROSS % LLY GROSS % FTRE FCF LLY FCF
FY 2025 $2.72B $65.18B 44.0% 83.0% -$9.1M $16.81B
FY 2024 $2.70B $45.04B 44.0% 81.3% $141.5M $8.82B
FY 2023 $2.84B $34.12B 44.0% 79.3% $40.5M $4.24B
FY 2022 — $28.54B — 76.8% — $7.59B
FY 2021 — $28.32B — 74.2% — $7.37B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FTRE // BETA 0.99
LLY // BETA 0.51